메뉴 건너뛰기




Volumn 444, Issue 1-2, 2013, Pages 18-24

Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products

Author keywords

Bioavailability; Crystallinity; Dissolution; Lovastatin; Red yeast rice

Indexed keywords

CHOLESTIN; HYPOCHOLESTEROLEMIC AGENT; LIPOCOL FORTE; LOVASTA; MEVINOLIN; UNCLASSIFIED DRUG; XUEZHIKANG;

EID: 84873699629     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.01.028     Document Type: Article
Times cited : (66)

References (31)
  • 3
    • 46749098263 scopus 로고    scopus 로고
    • Simvastatin vs therapeutic lifestyle changes and supplements: Randomized primary prevention trial
    • D.J. Becker, R.Y. Gordon, P.B. Morris, J. Yorko, Y.J. Gordon, M. Li, and N. Iqbal Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial Mayo Clin. Proc. 83 2008 758 764
    • (2008) Mayo Clin. Proc. , vol.83 , pp. 758-764
    • Becker, D.J.1    Gordon, R.Y.2    Morris, P.B.3    Yorko, J.4    Gordon, Y.J.5    Li, M.6    Iqbal, N.7
  • 4
    • 0021139131 scopus 로고
    • Fluorimetric determination of critical micelle concentration avoiding interference from detergent charge
    • A. Chattopadhyay, and E. London Fluorimetric determination of critical micelle concentration avoiding interference from detergent charge Anal. Biochem. 139 1984 408 412
    • (1984) Anal. Biochem. , vol.139 , pp. 408-412
    • Chattopadhyay, A.1    London, E.2
  • 5
    • 15344341734 scopus 로고    scopus 로고
    • Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1
    • C. Chen, R.J. Mireles, S.D. Campbell, J. Lin, J.B. Mills, J.J. Xu, and T.A. Smolarek Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1 Drug Metab. Dispos. 33 2005 537 546
    • (2005) Drug Metab. Dispos. , vol.33 , pp. 537-546
    • Chen, C.1    Mireles, R.J.2    Campbell, S.D.3    Lin, J.4    Mills, J.B.5    Xu, J.J.6    Smolarek, T.A.7
  • 6
    • 84871447117 scopus 로고    scopus 로고
    • Interaction between red yeast rice and CYP450 enzymes/P-glycoprotein and its implication for the clinical pharmacokinetics of lovastatin
    • Article ID 127043
    • C.H. Chen, Y.S. Uang, S.T. Wang, J.C. Yang, and C.J. Lin Interaction between red yeast rice and CYP450 enzymes/P-glycoprotein and its implication for the clinical pharmacokinetics of lovastatin Evid. Based Complement. Alternat. Med. 2012 10 Article ID 127043
    • (2012) Evid. Based Complement. Alternat. Med. , pp. 10
    • Chen, C.H.1    Uang, Y.S.2    Wang, S.T.3    Yang, J.C.4    Lin, C.J.5
  • 7
    • 0031913402 scopus 로고    scopus 로고
    • Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms
    • J.B. Dressman, G.L. Amidon, C. Reppas, and V.P. Shah Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms Pharm. Res. 15 1998 11 22
    • (1998) Pharm. Res. , vol.15 , pp. 11-22
    • Dressman, J.B.1    Amidon, G.L.2    Reppas, C.3    Shah, V.P.4
  • 8
    • 0031750861 scopus 로고    scopus 로고
    • Evaluation of various dissolution media for predicting in vivo performance of class i and II drugs
    • E. Galia, E. Nicolaides, D. Hörter, R. Löbenberg, C. Reppas, and J.B. Dressman Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs Pharm. Res. 15 1998 698 705
    • (1998) Pharm. Res. , vol.15 , pp. 698-705
    • Galia, E.1    Nicolaides, E.2    Hörter, D.3    Löbenberg, R.4    Reppas, C.5    Dressman, J.B.6
  • 9
    • 0032898925 scopus 로고    scopus 로고
    • Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement
    • D. Heber, I. Yip, J.M. Ashley, D.A. Elashoff, R.M. Elashoff, and V.L. Go Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement Am. J. Clin. Nutr. 69 1999 231 236
    • (1999) Am. J. Clin. Nutr. , vol.69 , pp. 231-236
    • Heber, D.1    Yip, I.2    Ashley, J.M.3    Elashoff, D.A.4    Elashoff, R.M.5    Go, V.L.6
  • 10
    • 34250620912 scopus 로고    scopus 로고
    • Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients
    • C.F. Huang, T.C. Li, C.C. Lin, C.S. Liu, H.C. Shih, and M.M. Lai Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients Eur. J. Cardiovasc. Prev. Rehabil. 14 2007 438 440
    • (2007) Eur. J. Cardiovasc. Prev. Rehabil. , vol.14 , pp. 438-440
    • Huang, C.F.1    Li, T.C.2    Lin, C.C.3    Liu, C.S.4    Shih, H.C.5    Lai, M.M.6
  • 11
    • 0031954328 scopus 로고    scopus 로고
    • Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid
    • T. Kantola, K.T. Kivistö, and P.J. Neuvonen Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid Clin. Pharmacol. Ther. 63 1998 397 402
    • (1998) Clin. Pharmacol. Ther. , vol.63 , pp. 397-402
    • Kantola, T.1    Kivistö, K.T.2    Neuvonen, P.J.3
  • 12
    • 67650564624 scopus 로고    scopus 로고
    • Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia
    • M. Klimek, S. Wang, and A. Ogunkanmi Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia P. T. 34 2009 313 327
    • (2009) P. T. , vol.34 , pp. 313-327
    • Klimek, M.1    Wang, S.2    Ogunkanmi, A.3
  • 13
    • 36549034768 scopus 로고    scopus 로고
    • Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths
    • S. Lewington, G. Whitlock, R. Clarke, P. Sherliker, J. Emberson, J. Halsey, N. Qizilbash, R. Peto, and R. Collins Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths Lancet 370 2007 1829 1839
    • (2007) Lancet , vol.370 , pp. 1829-1839
    • Lewington, S.1    Whitlock, G.2    Clarke, R.3    Sherliker, P.4    Emberson, J.5    Halsey, J.6    Qizilbash, N.7    Peto, R.8    Collins, R.9
  • 15
    • 27944482535 scopus 로고    scopus 로고
    • Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia
    • C.C. Lin, T.C. Li, and M.M. Lai Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia Eur. J. Endocrinol. 153 2005 679 686
    • (2005) Eur. J. Endocrinol. , vol.153 , pp. 679-686
    • Lin, C.C.1    Li, T.C.2    Lai, M.M.3
  • 16
    • 34250741897 scopus 로고    scopus 로고
    • Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: A meta-analysis of randomized controlled trials
    • article 4
    • J. Liu, J. Zhang, Y. Shi, S. Grimsgaard, T. Alraek, and V. Fønnebø Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials Chin. Med. 1 2006 article 4
    • (2006) Chin. Med. , vol.1
    • Liu, J.1    Zhang, J.2    Shi, Y.3    Grimsgaard, S.4    Alraek, T.5    Fønnebø, V.6
  • 17
    • 44749084870 scopus 로고    scopus 로고
    • Effect of xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction
    • Z. Lu, W. Kou, B. Du, Y. Wu, S. Zhao, O.A. Brusco, J.M. Morgan, D.M. Capuzzi, and S. Li Effect of xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction Am. J. Cardiol. 101 2008 1689 1693
    • (2008) Am. J. Cardiol. , vol.101 , pp. 1689-1693
    • Lu, Z.1    Kou, W.2    Du, B.3    Wu, Y.4    Zhao, S.5    Brusco, O.A.6    Morgan, J.M.7    Capuzzi, D.M.8    Li, S.9
  • 18
    • 45549091043 scopus 로고    scopus 로고
    • Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin
    • P.J. Neuvonen, J.T. Backman, and M. Niemi Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin Clin. Pharmacokinet. 47 2008 463 474
    • (2008) Clin. Pharmacokinet. , vol.47 , pp. 463-474
    • Neuvonen, P.J.1    Backman, J.T.2    Niemi, M.3
  • 19
    • 33845420011 scopus 로고    scopus 로고
    • Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
    • P.J. Neuvonen, M. Niemi, and J.T. Backman Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance Clin. Pharmacol. Ther. 80 2006 565 581
    • (2006) Clin. Pharmacol. Ther. , vol.80 , pp. 565-581
    • Neuvonen, P.J.1    Niemi, M.2    Backman, J.T.3
  • 20
    • 84874341518 scopus 로고    scopus 로고
    • Merck & Co.; Inc. Whitehouse Station, NJ 08889, USA
    • Package insert of Mevacor 2012 Merck & Co.; Inc. Whitehouse Station, NJ 08889, USA http://www.accessdata.fda.gov/drugsatfda-docs/label/2012/ 019643s085lbl.pdf
    • (2012) Package Insert of Mevacor
  • 21
    • 63649143585 scopus 로고    scopus 로고
    • Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques
    • M. Patel, A. Tekade, S. Gattani, and S. Surana Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques AAPS PharmSciTech. 9 2008 1262 1269
    • (2008) AAPS PharmSciTech. , vol.9 , pp. 1262-1269
    • Patel, M.1    Tekade, A.2    Gattani, S.3    Surana, S.4
  • 22
    • 0036073540 scopus 로고    scopus 로고
    • Food-drug interactions
    • L.E. Schmidt, and K. Dalhoff Food-drug interactions Drugs 62 2002 1481 1502
    • (2002) Drugs , vol.62 , pp. 1481-1502
    • Schmidt, L.E.1    Dalhoff, K.2
  • 23
    • 0025944198 scopus 로고
    • Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin
    • A.T. Serajuddin, S.A. Ranadive, and E.M. Mahoney Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin J. Pharm. Sci. 80 1991 830 834
    • (1991) J. Pharm. Sci. , vol.80 , pp. 830-834
    • Serajuddin, A.T.1    Ranadive, S.A.2    Mahoney, E.M.3
  • 25
    • 84861049705 scopus 로고    scopus 로고
    • A systematic review of xuezhikang, an extract from red yeast rice, for coronary heart disease complicated by dyslipidemia
    • Article ID 636547
    • Q. Shang, Z. Liu, K. Chen, H. Xu, and J. Liu A systematic review of xuezhikang, an extract from red yeast rice, for coronary heart disease complicated by dyslipidemia Evid. Based Complement. Alternat. Med. 2012 18 Article ID 636547
    • (2012) Evid. Based Complement. Alternat. Med. , pp. 18
    • Shang, Q.1    Liu, Z.2    Chen, K.3    Xu, H.4    Liu, J.5
  • 26
    • 34047232844 scopus 로고    scopus 로고
    • Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles
    • G. Suresh, K. Manjunath, V. Venkateswarlu, and V. Satyanarayana Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles AAPS PharmSciTech. 8 2007 E162 E170
    • (2007) AAPS PharmSciTech. , vol.8
    • Suresh, G.1    Manjunath, K.2    Venkateswarlu, V.3    Satyanarayana, V.4
  • 27
    • 84874290358 scopus 로고    scopus 로고
    • Dissolution test for lovastatin tablet
    • Usp United States Pharmacopeial Convention pp. 2816-2817
    • USP Dissolution test for lovastatin tablet United States Pharmacopeia National Formulary, USP32 2009 United States Pharmacopeial Convention pp. 2816-2817
    • (2009) United States Pharmacopeia National Formulary, USP32
  • 28
    • 0025944905 scopus 로고
    • Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes
    • R.W. Wang, P.H. Kari, A.Y. Lu, P.E. Thomas, F.P. Guengerich, and K.P. Vyas Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes Arch. Biochem. Biophys. 290 1991 355 361
    • (1991) Arch. Biochem. Biophys. , vol.290 , pp. 355-361
    • Wang, R.W.1    Kari, P.H.2    Lu, A.Y.3    Thomas, P.E.4    Guengerich, F.P.5    Vyas, K.P.6
  • 29
    • 78650180318 scopus 로고    scopus 로고
    • Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs
    • C. Wu, Z. Wang, Z. Zhi, T. Jiang, J. Zhang, and S. Wang Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs Int. J. Pharm. 403 2011 162 169
    • (2011) Int. J. Pharm. , vol.403 , pp. 162-169
    • Wu, C.1    Wang, Z.2    Zhi, Z.3    Jiang, T.4    Zhang, J.5    Wang, S.6
  • 30
    • 17644380257 scopus 로고    scopus 로고
    • Predicting drug disposition via application of BCS: Transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system
    • C.Y. Wu, and L.Z. Benet Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system Pharm. Res. 22 2005 11 23
    • (2005) Pharm. Res. , vol.22 , pp. 11-23
    • Wu, C.Y.1    Benet, L.Z.2
  • 31
    • 33847223472 scopus 로고    scopus 로고
    • Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: Subgroup analysis of patients with type 2 diabetes from China Coronary Secondary Prevention study (CCSPS)
    • S.P. Zhao, Z.L. Lu, B.M. Du, Z. Chen, Y.F. Wu, X.H. Yu, Y.C. Zhao, L. Liu, H.J. Ye, and Z.H. Wu Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China Coronary Secondary Prevention study (CCSPS) J. Cardiovasc. Pharmacol. 49 2007 81 84
    • (2007) J. Cardiovasc. Pharmacol. , vol.49 , pp. 81-84
    • Zhao, S.P.1    Lu, Z.L.2    Du, B.M.3    Chen, Z.4    Wu, Y.F.5    Yu, X.H.6    Zhao, Y.C.7    Liu, L.8    Ye, H.J.9    Wu, Z.H.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.